EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
Hacker News·21d ago·5 min read
CBP suspends all personal prescription importation Oct 22
TL;DR
The U.S. Customs and Border Protection (CBP) has suspended all personal importation of prescription drugs as of October 22, impacting consumers seeking affordable medications from Canada.
✦ Why It Matters
Consider discussing alternative medication sources with your healthcare provider today.
Key Takeaways
- Explore local pharmacy options for affordable medications.
- Investigate patient assistance programs for prescription costs.
- Stay informed about changes in drug importation regulations.
- Advocate for policy changes to improve access to affordable drugs.
Full Summary
U.S. Customs and Border Protection (CBP) announced a suspension of all personal prescription drug importation effective October 22.
This move affects individuals who have been purchasing less expensive medications from licensed Canadian pharmacies, which are known for their safety records. The suspension is likely to increase costs for many Americans who rely on these imports for affordable healthcare.
The decision comes amid ongoing debates about drug pricing and access to medications in the U.S. The implications of this suspension could lead to a rise in out-of-pocket expenses for consumers, particularly those without insurance or with high deductibles.
As a result, many may need to explore alternative options for obtaining necessary prescriptions.